Carroll David Francis's Form 4 filing
IVERIC bio, Inc. (ISEE) · filed Dec 21, 2021
- Accession no.
- 0001104659-21-152294
- Filed
- Dec 21, 2021
- Trade date
- Dec 18-20, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $103.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carroll David FrancisCIK 0001703623 | Officer (SVP, CFO and Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2021 | Common Stock | MOption exerciseDisposed | −14,375 | $0.00 | $0 | 43,125 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
Referenced by the price of 1 transaction in Table I.
- F3
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker on December 20, 2021 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees.
Referenced by the price of 1 transaction in Table I.